COVID-19: Medical testing labs sought to qualify and quantify a new mass testing system for Covid-19 using advanced laser techniques

The UK company working with a UAE developer is offering a means to “mass test” and perform individual testing for viral infection using advanced laser techniques (DPI) on a drop of blood from the patient. The DPI method is a non-evasive testing system, that is confined to a portable unit, low technical knowledge and medical training to operate the unit. It does not rely on a laboratory to analyse the results. The unit has a screen to show the image from the DPI testing. This allows the product to be used by medical staff for close analysis, at the same time the cloud-based AI will determine the results. The system is currently used as the main mass testing for all boarders of the UAE. It has been sold to 26 other mid and far east countries. The company is seeking medical testing laboratories working in viral control, vaccination trails and medical screening, to use the product and participate in the control and monitoring of patients, with the ability to test and monitor with the need for a laboratory for clinical trials. The company is seeking medical testing laboratories whose key research is of viral infection control, to help qualify and quantify this testing method in the UK and Europe, via technical cooperation agreement.